Position in AZN
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$170,324,911
New position
Shares Held
863,629
first reported quarter
Ownership
0.056%
of shares outstanding
% of Portfolio
2.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 90.8680695066979.ToString("F0")%
Shared 0.ToString("F0")%
None 9.131930493302102.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GROUPAMA ASSET MANAGMENT holds $418,001,230 across 10 Drug Manufacturers - General names. AZN ranks #1 (40.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
863,629 | $170,324,911 | |
| 2 | MRK |
Merck & Co., Inc.
|
874,963 | $105,249,299 | |
| 3 | LLY |
ELI LILLY & Co
|
95,376 | $87,723,983 | |
| 4 | ABBV |
AbbVie Inc.
|
156,150 | $33,961,063 | |
| 5 | JNJ |
Johnson & Johnson
|
22,693 | $5,547,076 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,990 | $5,294,666 | |
| 7 | AMGN |
Amgen Inc
|
14,960 | $5,263,676 | |
| 8 | PFE |
Pfizer Inc
|
63,889 | $1,794,003 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $170,324,911 | 863,629 | Shares | Sole | 2026-05-22 | |
| No filing history on record for this holder in this stock. | ||||||